Skip to content
BIO Investment Council will bring together VC and small biotechs to boost innovation
In an initiative to accelerate capital formation for biotech innovation, the Biotechnology Innovation ...
Read More
BIO warns of risks from change to CDC’s vaccine recommendations
The Biotechnology Innovation Organization (BIO) warned that new changes in federal recommendations for ...
Read More
Using AI In patent practice: Practical and ethical issues
The use of AI tools in the workplace is on the rise. This ...
Read More
BIO IP Conference looks at academics and perceptions of IP
The post-COVID era has been especially hard on patent lawyers working in the ...
Read More
Patient advocates urge action on PPRV to help fight rare disease
Patient advocates retold emotional stories of lives saved, changed—or at risk—as they discussed ...
Read More
Who invented what? BIO IP panel tackles joint inventorship
We sometimes imagine the inventor of a patent as a lone vanguard leading ...
Read More
EDITORS' CHOICE
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More
LATEST NEWS
BIO's View
BIO Investment Council will bring together VC and small biotechs to boost innovation
In an initiative to accelerate capital formation for biotech innovation, the Biotechnology Innovation Organization (BIO) on Jan. 7 launched the BIO Investment Council (BIC), which ...
BIO's View
BIO warns of risks from change to CDC’s vaccine recommendations
The Biotechnology Innovation Organization (BIO) warned that new changes in federal recommendations for the childhood vaccination schedule are unscientific and put children’s health at risk. ...
Federal Policy
Using AI In patent practice: Practical and ethical issues
The use of AI tools in the workplace is on the rise. This trend is equally true in the arena of patent practice. However, given ...
Federal Policy
BIO IP Conference looks at academics and perceptions of IP
The post-COVID era has been especially hard on patent lawyers working in the biopharma space. “I don’t think it’s an accident that during the COVID ...
Federal Policy
Patient advocates urge action on PPRV to help fight rare disease
Patient advocates retold emotional stories of lives saved, changed—or at risk—as they discussed one of the most important factors enabling breakthroughs in fighting rare diseases, ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
Charlotte emerging as a global leader in health care innovation and med tech
Historically, Charlotte has been recognized as a major U.S. financial hub. Now, the city is making significant strides in another ...
Read More
International
Bio's View
BIO Investment Council will bring together VC and small biotechs to boost innovation
In an initiative to accelerate capital formation for biotech innovation, the Biotechnology Innovation Organization (BIO) on Jan. 7 launched the ...
Read More
